Includes bibliographical references.Inducing broadly neutralizing antibodies targeting the HIV-1 envelope is thought to be crucial for developing an effective vaccine. The Membrane Proximal External Region (MPER) within the HIV- 1 gp41 envelope is a promising vaccine target. The MPER is highly conserved, functionally constrained, facilitates virus fusion and is targeted by broadly neutralizing monoclonal antibodies. The objectives of this research were 1) To evaluate the neutralization breadth of antibodies induced by epitopes within the MPER compared to the PG9/16-site in chronically HIV-1-infected individuals, 2) to identify neutralization resistant HIV-1 isolates (using plasma samples infected with the same subtype) and to characterize t...
Thesis (Ph.D.)--University of Washington, 2014Eliciting a neutralizing antibody (Nab) response that ...
Author Summary Understanding how HIV-1-broadly neutralizing antibodies (bnAbs) develop during natura...
Background: The development of an effective AIDS vaccine has been a formidable task, but remains a c...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
The first antibody-inducing HIV-1 vaccines are unlikely to protect against all HIV-1 isolates. There...
A thesis submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,...
Although the development of an effective vaccine is the main goal in the fight against AIDS, all att...
Human Immunodeficiency Virus (HIV) is a T-lymphotrophic retrovirus that is the causative agent of Ac...
We identified three cross-neutralizing plasma samples with high-titer anti-membrane proximal externa...
Although human immunodeficiency type 1 (HIV-1) infection induces strong antibody responses to the vi...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
© 2016 Dr Vani Geetha Samanthi NarasimhuluThe trimeric HIV-1 envelope glycoprotein (Env) complex, gp...
Abstract A human immunodeficiency virus type-1 (HIV-1) vaccine which is able to effectively prevent ...
The study of the evolution and specificities of neutralizing antibodies during the course of human i...
Thesis (Ph.D.)--University of Washington, 2014Eliciting a neutralizing antibody (Nab) response that ...
Author Summary Understanding how HIV-1-broadly neutralizing antibodies (bnAbs) develop during natura...
Background: The development of an effective AIDS vaccine has been a formidable task, but remains a c...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
The first antibody-inducing HIV-1 vaccines are unlikely to protect against all HIV-1 isolates. There...
A thesis submitted to the Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,...
Although the development of an effective vaccine is the main goal in the fight against AIDS, all att...
Human Immunodeficiency Virus (HIV) is a T-lymphotrophic retrovirus that is the causative agent of Ac...
We identified three cross-neutralizing plasma samples with high-titer anti-membrane proximal externa...
Although human immunodeficiency type 1 (HIV-1) infection induces strong antibody responses to the vi...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
© 2016 Dr Vani Geetha Samanthi NarasimhuluThe trimeric HIV-1 envelope glycoprotein (Env) complex, gp...
Abstract A human immunodeficiency virus type-1 (HIV-1) vaccine which is able to effectively prevent ...
The study of the evolution and specificities of neutralizing antibodies during the course of human i...
Thesis (Ph.D.)--University of Washington, 2014Eliciting a neutralizing antibody (Nab) response that ...
Author Summary Understanding how HIV-1-broadly neutralizing antibodies (bnAbs) develop during natura...
Background: The development of an effective AIDS vaccine has been a formidable task, but remains a c...